P575: IMPACT OF MOLECULAR RESPONSE AND CHEMOTHERAPY REGIMEN ON OUTCOMES IN CORE BINDING FACTOR AML. (23rd June 2022) - Senapati, J.; Haddad, F.; Ravandi, F.; Kadia, T.; DiNardo, C.; Daver, N.; Pemmaraju, N.; Alvarado, Y.; Brandt, M. A.; Kantarjian, H.; Borthakur, G.